Viatris Total Current Assets 2010-2024 | VTRS

Viatris total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
  • Viatris total current assets for the quarter ending September 30, 2024 were $11.308B, a 3.44% increase year-over-year.
  • Viatris total current assets for 2023 were $12.976B, a 22.01% increase from 2022.
  • Viatris total current assets for 2022 were $10.635B, a 2.45% decline from 2021.
  • Viatris total current assets for 2021 were $10.903B, a 15.27% decline from 2020.
Viatris Annual Total Current Assets
(Millions of US $)
2023 $12,976
2022 $10,635
2021 $10,903
2020 $12,868
2019 $6,757
2018 $6,368
2017 $7,213
2016 $7,523
2015 $6,473
2014 $6,441
2013 $4,471
2012 $3,903
2011 $3,569
2010 $3,559
2009 $3,285
Viatris Quarterly Total Current Assets
(Millions of US $)
2024-09-30 $11,308
2024-06-30 $11,792
2024-03-31 $12,924
2023-12-31 $12,976
2023-09-30 $10,932
2023-06-30 $9,778
2023-03-31 $9,630
2022-12-31 $10,635
2022-09-30 $10,488
2022-06-30 $11,177
2022-03-31 $11,744
2021-12-31 $10,903
2021-09-30 $11,308
2021-06-30 $11,750
2021-03-31 $12,319
2020-12-31 $12,868
2020-09-30 $7,335
2020-06-30 $6,465
2020-03-31 $6,601
2019-12-31 $6,757
2019-09-30 $6,645
2019-06-30 $6,265
2019-03-31 $6,262
2018-12-31 $6,368
2018-09-30 $6,542
2018-06-30 $6,298
2018-03-31 $6,761
2017-12-31 $7,213
2017-09-30 $7,267
2017-06-30 $6,966
2017-03-31 $7,066
2016-12-31 $7,523
2016-09-30 $7,965
2016-06-30 $12,187
2016-03-31 $6,628
2015-12-31 $6,473
2015-09-30 $6,486
2015-06-30 $7,891
2015-03-31 $7,426
2014-12-31 $6,441
2014-09-30 $5,818
2014-06-30 $4,477
2014-03-31 $4,342
2013-12-31 $4,471
2013-09-30 $4,343
2013-06-30 $4,212
2013-03-31 $3,950
2012-12-31 $3,903
2012-09-30 $3,751
2012-06-30 $3,752
2012-03-31 $3,739
2011-12-31 $3,569
2011-09-30 $3,609
2011-06-30 $3,760
2011-03-31 $3,757
2010-12-31 $3,559
2010-09-30 $3,463
2010-06-30 $3,629
2010-03-31 $3,355
2009-12-31 $3,285
2009-09-30 $3,262
2009-06-30 $3,023
2009-03-31 $2,912
Sector Industry Market Cap Revenue
Medical Medical Services $15.576B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00